Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX.

AUTOR(ES)

McGraw, R A

RESUMO

We have independently isolated and characterized cDNA and genomic clones for the human coagulation factor IX. Sequence analysis in both cases indicates that threonine is encoded by the triplet ACT as the third residue of the activation peptide. This is in agreement with some earlier reports but in disagreement with others that show the alanine triplet GCT at this position. The discrepancy can thus be accounted for by natural variation of a single nucleotide in the normal population. Amino acid sequence analyses of activated factor IX from plasma samples of four individuals yielded two cases of alanine and two cases of threonine at the third position of the activation peptide. In factor IX from pooled plasma and in factor IX from a heterozygous individual, however, both alanine and threonine were found. Taken together, the findings show that a prevalent nondeleterious dimorphism exists in the activation peptide of human coagulation factor IX.

Documentos Relacionados

• Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX.
• The gene structure of human anti-haemophilic factor IX.
• Isolation and characterization of a cDNA coding for human factor IX.
• Aspartyl beta-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IX.
• Identification of the endothelial cell binding site for factor IX.